In the United States right now, there are two FDA-approved medications for treatment of obesity or overweight in people who have medical co-morbidities, like high blood pressure, high cholesterol or sleep apnea. These drugs, semaglutide and tirzepatide, are sold under four different brand names: Ozempic, Mounjaro, Wegovy and Zepbound.
#glp1 #ozempic #zepbound #mounjaro #wegovy

Allison Rhodes, MD, an obesity medicine specialist at The Ohio State University Wexner Medical Center, explains which brand-name GLP-1 medication is prescribed for which types of conditions.

More about Weight Management at Ohio State: https://go.osu.edu/CyJe

More about Dr. Rhodes and how to schedule an appointment with her: https://go.osu.edu/CyJg

Subscribe to Ohio State articles and stories about health, wellness, medicine, science and education: http://go.osu.edu/HDsubscribe

0 Comments

Up next

Autoplay

Podcast Ep 19: Semaglutide (Ozempic) and the Rise of GLP-1 Receptors Agonists

1 Views . 08/29/25 Side Effects

Please note that if you are under 18, you won't be able to access this site.

Up next

Ozempic, Mounjaro, Wegovy, Zepbound: Who can take which one? | Ohio State Medical Center

Up next

Language